- Home
- Advocacy
- Areas of Work
- Conferences & Events
- BIO International Convention
- BIO Business Forum
- BIO CEO & Investor Conference
- BIO China International Conference
- BIO Executive Training Programs
- BIO IP Counsels Committee Conference
- BIO Legislative Day Fly-In
- BIO Livestock Summit
- BIO India International Conference
- BIO Investor Forum
- Pacific Rim Summit
- Partnering for Global Health
- BIO Advanced Business Development Course
- BioSafe Annual General Membership Meeting
- Biosecurity Conference
- BIO Asia International Conference
- BIO World Congress on Industrial Biotechnology and Bioprocessing
- Technology Transfer Symposium
- Conference Descriptions
- Industry Intelligence & Analysis
- Member Services
- Resources
The 14th Annual BIO CEO & Investor Conference
The BIO CEO & Investor Conference is the largest investor conference focused on established and emerging publicly traded biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.
BIO One-on-One Partnering provides an opportunity to arrange meetings between investors; companies; and industry BD, licensing and therapeutic franchise heads.
Conference News and Updates
• Optimer Has Big Plans for Antibiotic: Article -- Hear more on February 14, 9:00am
• Program Grid Now Available: Download
• Pfizer President of WW R&D to speak in BIO CEO Fireside Chat: Program
• New Presenting Company Breakdown: Download
• Company Snapshot - NuPathe Inc: Blog
• Over 135 Companies Set to Present: List
• GSK Head of R&D to speak in BIO CEO Fireside Chat: Program
Presenting Company Highlights
• FDA Approves Roche, Curis Skin-Cancer Drug: Release
• EpiCept Announces FDA Permission: Release
• Trius Therapeutics Meets Study Goals: Article
• Rigel Announces Initiation: Release
• NovaBay Announces Agreement: Release
• Synta Rises as Analyst Weighs Drug: Article
• BioLineRx Announces Development: Release
• StemCells Announces Closing of Offering: Release
• CytRx Announces Initiation: Release
• Chelsea Reports Phase 2 Results: Release
Blog Posts from BIO’s BiotechNow
• Reviewing the drug class of 2011: Blog
• VC Recap for 2011 - Up or down? Blog
• NBI 2011 Performance: Blog
• IPO Update, January 2012: Blog
• VRUS / GILD Perspective: Blog
• Public Exits and virtual Biotech: Blog
• Perspective on Biotech Market Valuation: Blog
BIO Press Releases
• BIO CEO to Highight 2012 Investment Outlook: Release
• BIO CEO Introduces Fireside Chats: Release
• BIO CEO Highlights Latest Investment and Deal Making Trends: Release
• BIO Announces CEO & Investor Conference Presenting Companies: Release
Local Co-Host
Supporting Bank Sponsors
Double Helix Sponsors
Helix Sponsors
Conference Sponsors
